Michael G. Kauffman
2013
In 2013, Michael G. Kauffman earned a total compensation of $7.3M as Chief Executive Officer at Karyopharm Therapeutics, a 1,483% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $170,000 |
---|---|
Option Awards | $6,771,948 |
Salary | $380,507 |
Other | $10,258 |
Total | $7,332,713 |
Kauffman received $6.8M in option awards, accounting for 92% of the total pay in 2013.
Kauffman also received $170K in non-equity incentive plan, $380.5K in salary and $10.3K in other compensation.
Rankings
In 2013, Michael G. Kauffman's compensation ranked 739th out of 12,286 executives tracked by ExecPay. In other words, Kauffman earned more than 94.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 739 | 94th |
Manufacturing | 240 | 95th |
Chemicals And Allied Products | 65 | 96th |
Drugs | 40 | 97th |
Pharmaceutical Preparations | 36 | 96th |
Kauffman's colleagues
We found two more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2013.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019